Genmab — Juli 2016
-
Hans retorik er den samme. Vinklingen går dog på at finde den næste blockbuster.
-
Lidt flavour på M&A situationen i biotechhttp://whbl.com/news/articles/2016/jul/19/old-pharma-sees-new-profit-cure-in-cancer-drugs/
-
J&J Q2 webcast: http://edge.media-server.com/m/p/5qz4bkwd
-
Så kommer raketten
-
hejsa. hvad tid er regnskab for J
-
det må da være snart, hvis det er inden ( call) kl
14.30 -
kl 13.00 normalt
-
takker
-
AB slugte lige 4-5000 genmab til middag
-
-
"Other Oncology" steg fra 18 millioner sidste år til 139 millioner i år
-
Den kategory som Dara er i
-
Så Dara salget er omkring de 120 millioner $ ca.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind